FDA Trails EMA in Getting Patient Perspective in Drug Development

Drug Industry Daily
The FDA is taking steps toward getting more patient input during the drug development process, a move that puts the agency more in line with its EU counterparts, agency officials said Thursday at the DIA annual meeting.

To View This Article:


Subscribe To Drug Industry Daily